The association between LPAR1 and tumor-infiltrating immune cells in multiple cancer types was based on the TIMER database, including breast cancer, head and neck cancer, colorectal cancer, kidney cancer, and prostate cancer (Figure S1). This evidence concerns the gene LPAR1 and kidney cancer.